Approval times and the safety of new pharmaceuticals
Author:
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Link
http://link.springer.com/content/pdf/10.1007/s10198-004-0247-0.pdf
Reference10 articles.
1. Andersson F, Hertzman P (1993) Effective patent life of drugs in Sweden?a comparison with international studies. Manage Decis Econ 14:53?63
2. Bakke OM, Manocchia M, Deabajo F, Kaitin KI, Lasagna L (1995) Drug safety discontinuations in the United Kingdom, the United States and Spain from 1974 through 1993?a regulatory perspective. Clin Pharmacol Ther 58:108?117
3. Cameron AC, Trivedi PK (1998) Regression analysis of count data. Cambridge University Press: Cambridge
4. Hausman JA, Hall BH, Griliches Z (1984) Econometric models for count data with an application to the patents?R and D relationship. Econometrica 52:909?938
5. Olson MK (1995) Regulatory agency discretion among competing industries: inside the FDA. J Law Econ Organ 11:379?405
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation;American Economic Journal: Economic Policy;2010-11-01
2. Pharmaceutical Pricing and Reimbursement Policies in Sweden;SSRN Electronic Journal;2007
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3